COMP <GO>
DCI vs TMO // 10Y YIELD & FRED MACRO BETA
Donaldson Company Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: DCI 7
— TMO 8
▲ 10Y YIELD & FRED MACRO BETA LEADER: DCI
LAST: $82.96 (-2.73%) • MKT CAP: $9.89B
macro-sensitivity
1.04
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
macro-sensitivity
0.94
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DCI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DCI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 34.80% | 41.00% | -6.20 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 19.50% | 9.30% | +10.20 | DCI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.3x | 30.4x | -12.10 | DCI | /valuation <GO> |
| Free Cash Flow Yield | 3.44% | 2.40% | +1.04 | DCI | /fcf-yield <GO> |
| Operating Margin | 13.40% | 17.40% | -4.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | 9.90% | 15.10% | -5.20 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 1.10% | 3.90% | -2.80 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.33% | 0.24% | +1.09 | DCI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.33 | 4.50 | +2.83 | DCI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.70% | +0.30 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 31.6 | 59.1 | -27.50 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.04 | 0.94 | +0.10 | DCI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 25.0x | 36.3x | -11.30 | DCI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.89B | $262.22B | -$252.33B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DCI REV | TMO REV | DCI GROSS % | TMO GROSS % | DCI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.69B | $44.56B | 34.8% | 44.0% | $339.9M | $6.29B |
| FY 2024 | $3.59B | $42.88B | 35.5% | 44.0% | $406.9M | $7.27B |
| FY 2023 | $0 | $42.86B | — | 44.0% | $544.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DCI // BETA 1.04
TMO // BETA 0.94